Diagnosis, Staging and Treatment of Patients with Gestational Trophoblastic Disease

Guideline Number: 13

Publication Date: November 2015

Update on National Clinical Guideline No. 13 Diagnosis, Staging and Treatment of Patients with Gestational Trophoblastic Disease on 13th May 2022

The National Clinical Guideline No. 13 Diagnosis, Staging and Treatment of Patients with Gestational Trophoblastic Disease, published in 2015, is today retired from the suite of NCEC National Clinical Guidelines and as such is no longer available on this webpage.

It has now been updated by the HSE’s National Cancer Control Programme (NCCP) and is called The NCCP National Clinical Guideline Diagnosis, Staging and Treatment of Patients with Gestational Trophoblastic Disease. It is available on the NCCP website.

Please note the new guideline (2022) supersedes the recommendations of the previous guideline National Clinical Guideline No. 13 Diagnosis, Staging and Treatment of Patients with Gestational Trophoblastic Disease (2015).

If you wish to see a copy of the above complete originally published NCEC guideline for clinical reasons, please contact the HSE National Cancer Control Programme at info@cancercontrol.ie

If you require the above complete originally published NCEC guideline for any other reason (e.g. research etc) please contact the Clinical Effectiveness Unit in the Department of Health at ncec@health.gov.ie